Skip to content
Disability, Medical Health Aged Care

Allied Health and Disability Sector’s Finest To Be Recognised at 2024 Heart of Health and Disability Awards

The Heart of Health and Disability Conference and Awards 2 mins read

90 exceptional allied health and disability individuals and businesses will be celebrated and recognised as part of the prestigious 2024 Heart of Health and Disability Conference and Awards on 18 July 2024 at Sharks Event Centre.

Gold Coast, Australia - 17 June, 2024

The Heart of Health and Disability Conference and Awards (HOHAD) is excited to announce the 2024 Heart of Health and Disability Conference and Awards, set to take place on 18 July 2024 at The Sharks Event Centre, Gold Coast. 

The 2024 Heart of Health and Disability Conference and Awards features three events over two days:

  • A networking evening on 17 July 2024: a unique opportunity for allied health and NDIS professionals to connect, share experiences, and build meaningful relationships. This informal setting aims to foster collaboration and support among attendees, creating a strong sense of community.
  • A full-day conference on 18 July 2024: Burnout has become an accepted norm amongst allied health and NDIS professionals. HOHAD is changing this narrative, providing attendees with insights and practical strategies to equip health and disability professionals with the tools they need to combat burnout and excel in their careers.
  • The event's highlight is the awards gala on 18 July 2024, where 90 outstanding individuals and businesses in the allied health and disability sectors will be honoured for their exceptional contributions. These awards recognise those who go above and beyond to make a positive impact on the lives of others and set a high standard for the industry. 

"HOHAD is committed to changing the narrative around burnout in the allied health and disability sectors," said Karina Follent, Founder of HOHAD. "Our conference and awards provide a platform to recognise the incredible work being done by professionals in these fields and to promote practices that enhance their well-being and effectiveness. We believe that celebrating excellence and fostering a supportive community can drive positive change and improve access to quality services for all Australians."

For more information about the 2024 Heart of Health and Disability Conference and Awards, visit www.heartevents.com.au.


About us:

The Heart of Health and Disability Conference and Awards is an annual event dedicated to connecting, inspiring, recognising, and celebrating professionals in the allied health and disability industries. Founded by Karina Follent, HOHAD aims to combat burnout, promote resilience, and improve access to quality health and disability services through its comprehensive program of events and awards.


Contact details:

Karina Follent

karina@heartevents.com.au

0412 410 659

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.